Cochrane backs antiplatelets to prevent pre-eclampsia
Administration to 1000 women saves 20 pregnancies from serious adverse events
27th November 2019
Antiplatelet agents, such as aspirin and dipyridamole, are safe and effective for preventing pre-eclampsia and its complications, according to a Cochrane review.
Dr Lelia Duley of Nottingham Health Science Partners, in the UK, and colleagues assessed the effectiveness and safety of antiplatelet drugs for preventing pre-eclampsia and its complications in their systematic review of 77 randomised trials, including more than 40,000 women and their babies.
Low-dose aspirin (75mg per day or less) was the sole intervention in all of the large
